Trial intelligence / Profile preview

PTH 1-34 Treatment for Hypoparathyroidism

NCT00001304Phase 2Completed

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Start
Oct 1991
Primary completion
Mar 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of teriparatide in hypoparathyroidism, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Oct 1991; status: completed.

02

Drugs

teriparatide
03

Conditions

hypoparathyroidism

Beyond the preview

Go deeper on NCT00001304.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001304.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call